When considered separately from other cardiovascular diseases, stroke ranks third among all causes of death, after heart disease and cancer.Worldwide, 3 million women and 2.5 million men die each year from stroke. Hemorrhagic stroke occurs when a blood vessel, typically an aneurysm, ruptures inside the brain. This often leads to severe disability or death. Despite considerable advances in treatment, rupture is associated with exceptionally high levels of morbidity and mortality - about 33% in each case.
Currently, invasive or minimally invasive treatment is offered to almost all patients because there is insufficient evidence to support a decision of nonintervention. It is the primary thesis of @neurIST that the process of cerebral aneurysm diagnosis, treatment planning and development is significantly compromised by the fragmentation of relevant data.To address this issue, @neurIST is developing a complete IT infrastructure for the management and processing of heterogeneous data associated with the diagnosis and treatment of cerebral aneurysms.
@neurIST will transform the management of cerebral aneurysms by providing new insight, personalised risk assessment and methods for the design of improved medical devices and treatment protocols.
For further information, please visit:
http://www.aneurist.org
Project co-ordinator:
Universitat Pompeu Fabra
Partners:
Universitat Pompeu Fabra, Université de Genève, The University of Sheffield, Ecole Polytechnique Fédérale de Lausanne, Fraunhofer Institute, Institut Municipal d'Assistència Sanitària, Super Computing Solutions, Philips Medical Systems, Erasmus Medical Center, Royal Institute of Technology, GridSystems, ANSYS, NEC, University of Oxford, InferMed, Advanced Simulation & Design, William Cook, Institut National de la Santé et la Recherche Médicale, IDAC, Neuroangiografia Terapèutica, Hospital Clínic de Barcelona, University of Bedfordshire, Medical University of Pécs, Universitaet Wien, Universitätsklinikum Freiburg, Durham University, King's College London.
Timetable: from 01/06 - to 12/09
Total cost: € 17.356.730,92
EC funding: € 12.605.239
Instrument: IP
Project Identifier: IST-2004-027703